Home › Funds › Patient Square Capital LP › DFTX
Patient Square Capital LP position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
Patient Square Capital LP reported holding 385,000 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.7M, representing 2.34% of its reported portfolio and ranking #10 among its reported holdings. Patient Square Capital LP has disclosed DFTX holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's DFTX position evolved
Patient Square Capital LP first disclosed a stake in DFTX in Q1 2026 at 331,000 shares (US$6.3M). The position peaked in Q3 2026 at 385,000 shares, worth US$14.7M. Across 2 filings, Patient Square Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 385,000 shares valued at US$14.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 331.00K | $6.26M | New |
| Q3 2026 | 385.00K | $14.65M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 158 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held DFTX?
Patient Square Capital LP has disclosed DFTX holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Patient Square Capital LP's current position in DFTX?
As of Q3 2026, Patient Square Capital LP holds 385.00K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $14.65M, representing 2.34% of its reported portfolio and ranking #10.
Has Patient Square Capital LP been buying or selling DFTX?
In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in DFTX. The position peaked in Q3 2026 at 385.00K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 158 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.